Drug intelligence / Profile preview

Shen Qi Tiao Shen prescription

Development stage
Unknown
Lead developer
First Affiliated Hospital of Anhui University of Chinese Medicine
Administration
Oral
01

Overview

Shen Qi Tiao Shen prescription is a Traditional Chinese Medicine (TCM) herbal formula developed by The First Affiliated Hospital of Anhui University of Chinese Medicine. It is a component of the Xin'an Guben Peiyuan formula series, which is based on the Xin'an medical school's therapeutic principle of "strengthening the foundation and cultivating the source" (Guben Peiyuan). This specific prescription is designed to "regulate the kidney" (Tiao Shen) and is primarily investigated as an adjunctive therapy for patients with stable chronic obstructive pulmonary disease (COPD). In clinical studies, it is evaluated for its ability to improve lung function, reduce acute exacerbations, and enhance the quality of life when added to standard-of-care bronchodilators such as tiotropium. The formula typically contains botanical extracts known for their immunomodulatory and anti-inflammatory properties, such as *Astragalus membranaceus* (Huangqi) and *Panax ginseng* or *Codonopsis pilosula* (Shen).

Other names
Shenqi Tiaoshen prescriptionShenqi Tiaoshen formulaShen Qi Tiao Shen formulaXin'an Guben Peiyuan formula series

Beyond the preview

Go deeper on Shen Qi Tiao Shen prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shen Qi Tiao Shen prescription.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call